Filing Details
- Accession Number:
- 0001209191-21-033441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 15:19:03
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 15:19:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1584751 | Talis Biomedical Corp | TLIS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337801 | W. Randal Scott | C/O Talis Biomedical Corporation 230 Constitution Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-14 | 9,000 | $10.16 | 9,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-17 | 11,000 | $10.11 | 20,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,390,065 | Indirect | By Thinking Bench Capital, LLC |
Common Stock | 312,500 | Indirect | By OG Family Trust, u/d/t May 30, 2014 |
Footnotes
- This purchase was executed in multiple purchases at prices ranging from $10.03 to $10.25. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This purchase was executed in multiple purchases at prices ranging from $10.00 to $10.15. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.